ImmuCell Announces USDA Approval of Dual-Force™ First Defense®
ImmuCell Corporation (ICCC)
US:NASDAQ Investor Relations:
immucell.com/investors
Company Research
Source: GlobeNewswire
PORTLAND, Maine, Dec. 11, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced that the USDA has issued a product license for Dual-Force™ First Defense®. Dual-Force™ in a single-dose oral syringe provides guaranteed levels of E. coli and coronavirus antibodies to prevent scours in newborn calves. The gel tube delivery format is a preferred administration route for some, as an alternative to the Company’s longstanding First Defense® capsule. “Our goal is to formulate our efficacious colostrum antibodies into a variety of formats so that our customers can choose the option that works best for their operations,” commented Michael F. Brigham, President and CEO. “This regulatory validation should help us compete more effectively in the market and grow
Show less
Read more
Impact Snapshot
Event Time:
ICCC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ICCC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ICCC alerts
High impacting ImmuCell Corporation news events
Weekly update
A roundup of the hottest topics
ICCC
News
- ImmuCell reports preliminary Q1 sales, stock climbs 7% [Seeking Alpha]Seeking Alpha
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024GlobeNewswire
- ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 [Yahoo! Finance]Yahoo! Finance
- ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023GlobeNewswire
ICCC
Sec Filings
- 4/26/24 - Form DEF
- 4/10/24 - Form EFFECT
- 4/10/24 - Form 424B2
- ICCC's page on the SEC website